Results 41 to 50 of about 1,582 (168)

Pteridines and Lipid Metabolism

open access: yesPteridines, 1998
The effect of 9 different pteridines on fatty acid incorporation into phospholipids as well as on cholesterol and phospholipid content was compared in vitro using rat liver homogenate, Krebs-Ringer phosphate buffer containing 0.3 % albumin (pH=7.4 ...
Rudzite Vera   +5 more
doaj   +1 more source

Emerging pharmacotherapy for cancer patients with cognitive dysfunction [PDF]

open access: yes, 2013
Advances in the diagnosis and multi-modality treatment of cancer have increased survival rates for many cancer types leading to an increasing load of long-term sequelae of therapy, including that of cognitive dysfunction.
A Parachikova   +67 more
core   +2 more sources

Effects of Tetrahydrobiopterin (BH4) on S-Nitroso-N-acetyl-D,Lpenicillamine (SNAP)-Induced HL-60 Cell Death

open access: yesPteridines, 1998
First, we examined the effects of various chemical NO-donors on the cell damage in HL-60 cells. The most potent of these was S-nitroso-N-acetyl- penicillamine (SNAP).
Kojima Shuji
doaj   +1 more source

The Reaction Mechanism of Phenylalanine Hydroxylase. – A Question of Coordination

open access: yesPteridines, 2005
Phenylalanine hydroxylase (PAH) is a non-heme iron and tetrahydrobiopterin-dependent enzyme that catalyzes the hydroxylation of L-phenylalanine to L-tyrosine using dioxygen as additional substrate.
Teigen Knut   +2 more
doaj   +1 more source

Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis [PDF]

open access: yes, 2013
BACKGROUND: [(18) F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease.
A Stoessl   +6 more
core   +1 more source

Validating the GTP-cyclohydrolase 1-feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches. [PDF]

open access: yes, 2015
BACKGROUND AND PURPOSE: 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4 ) is an essential cofactor for nitric oxide biosynthesis. Substantial clinical evidence indicates that intravenous BH4 restores vascular function in patients.
Brown, PR   +8 more
core   +3 more sources

Insights from a Murine Aortic Transplantation Model [PDF]

open access: yes, 2016
Transplant vasculopathy (TV) represents a major obstacle to long-term graft survival and correlates with severity of ischemia reperfusion injury (IRI). Donor administration of the nitric oxide synthases (NOS) co-factor tetrahydrobiopterin has been shown ...
Bernhard, David   +11 more
core   +1 more source

Molecular Mechanisms of Endothelial Dysfunction in the Insulin-Resistant State: the Roles of Abnormal Pteridine Metabolism

open access: yesPteridines, 2003
Although abnormalities in endothelial function are described in various insulin-resistant conditions, including obesity, diabetes, and hypertension in both humans and animal models, the underlying mechanisms are poorly understood.
Shinozaki Kazuya   +3 more
doaj   +1 more source

Blocked dihydropteridines as nitric oxide synthase activators [PDF]

open access: yes, 2010
It has been shown that 6-acetyl-7,7-dimethyl-5,6,7,8-tetrahydropteridin-4(3H)-one can act as a competent cofactor for the production of nitric oxide by neuronal nitric oxide synthase (nNOS).
Daff, Simon   +5 more
core  

Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes. [PDF]

open access: yes, 2009
Vascular complications are an important pathological issue in diabetes that lead to the further functional deterioration of several organs. The balance between endothelium-dependent relaxing factors and endothelium-dependent contracting factors (EDCFs ...
Afkhami-Ardekani   +152 more
core   +1 more source

Home - About - Disclaimer - Privacy